Recursion Pharmaceuticals, Inc. · NASDAQ:RXRX

Vanguard Capital Management LLC reported a 5.09% stake in Recursion Pharmaceuticals, Inc. (Schedule 13G)

Event Jun 30, 2026 · Filed Jul 31, 2026

Vanguard Capital Management LLC reported a 5.09% stake in Recursion Pharmaceuticals, Inc., 26,744,129 shares, as a passive investor on Jun 30, 2026. Filed Jul 31, 2026 (Schedule 13G).

Stake
5.09%
Shares
26,744,129
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
Vanguard Capital Management5.09%26,744,129

Source

View original at SEC

Related